EQ Message Board Post 9665850 | Equillium Inc.
home / stock / eq / eq message board
M5cs
(investorshub)
Posted on: Nov/10/2020 22:40:03
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159413739
Any opinion on today's Q3-Filing updates. Don't find
News, Short Squeeze, Breakout and More Instantly...
-
Q2 ending cash, cash equivalents and short-term investments totaled approximately $33.3 million, an increase of approximately $1.0 million compared to the amount at the end of Q1 Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutic...
-
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will be participating in the Leerink Partners Therapeutic Forum: I&I and Metabolism, as well as the Jone...
-
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it expects to join the Russell Microcap Index at the conclusion of the 2024 Russell annual reconstitution, effe...